Q2 2022 13F Holders as of 30 Jun 2022
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
44,666,667
-
Total 13F shares
-
29,663,685
-
Share change
-
-423,841
-
Total reported value
-
$106,795,432
-
Price per share
-
$3.60
-
Number of holders
-
85
-
Value change
-
-$4,430,704
-
Number of buys
-
45
-
Number of sells
-
55
Institutional Holders of HARVARD BIOSCIENCE INC - Common Stock (HBIO) as of Q2 2022
As of 30 Jun 2022,
HARVARD BIOSCIENCE INC - Common Stock (HBIO) was held by
85 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
29,663,685 shares.
The largest 10 holders included
Harvey Partners, LLC, PUNCH & ASSOCIATES INVESTMENT MANAGEMENT, INC., Portolan Capital Management, LLC, DIMENSIONAL FUND ADVISORS LP, ROYCE & ASSOCIATES LP, B. Riley Asset Management, LLC, VANGUARD GROUP INC, Granahan Investment Management, LLC, AMH Equity Ltd, and BlackRock Inc..
This page lists
85
institutional shareholders reporting positions in this security
for the Q2 2022 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.